A multicenter evaluation of tuberculin skin test positivity and conversion among health care workers in Brazilian hospitals

Int J Tuberc Lung Dis. 2005 Dec;9(12):1335-42.

Abstract

Setting: Four general Brazilian hospitals.

Objective: To assess the occupational risk of Mycobacterium tuberculosis (TB) in participating hospitals.

Design: In phase one of this longitudinal study, a cross-sectional survey documented baseline tuberculin skin test (TST) positivity rates. In phase two, TST conversion rates were evaluated in participants with an initial negative two-step TST. TST conversion data were analyzed to determine risk factors for TB infection using an increase of > or = 10 mm compared to baseline TST.

Results: The initial TST positivity rate was 63.1%; the follow-up TST conversion rate was 10.7 per 1000 person-months (p-m). Hospital of employment, recent bacille Calmette-Guerin (BCG) vaccination, nosocomial TB exposure, and employment as a nurse were independent risk factors for TST conversion. Hospitals without TB infection control measures had higher conversion rates than those with control measures (16.0 vs. 7.8/ 1000 p-m, P < 0.001).

Conclusions: This study indicates an important occupational risk of infection in health care settings with a high TB incidence. Longitudinal TST studies are a valuable tool to assess the occupational risk of TB, even in BCG-vaccinated populations, and should be used to direct limited resources for infection control.

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • BCG Vaccine
  • Brazil
  • Female
  • Hospitals, General
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Occupational Diseases / epidemiology*
  • Occupational Diseases / etiology
  • Occupational Exposure / adverse effects*
  • Personnel, Hospital*
  • Risk Factors
  • Seroepidemiologic Studies
  • Tuberculin Test
  • Tuberculosis / epidemiology*
  • Tuberculosis / etiology
  • Tuberculosis / prevention & control

Substances

  • BCG Vaccine